California Life Sciences Political Action Committee

View

Source Type	Amount	Percentage
Other	$2.26M	94.1%
Committee	$80.3K	3.3%
Individual	$62K	2.6%
Total	$2.41M	100%

Itemized Group by Donor

Donor	Total Amount	% of Total
Astellas Gene Therapies Other	~$X,XXX	0.1%
Sana Biotechnology Other	~$X,XXX	0.1%
Orca Biosystems Other	~$X,XXX	0.1%
Element Biosciences Other	~$X,XXX	0.1%
Iovance Biotherapeutics Other	~$X,XXX	0.1%
Atreca, Inc. Other	~$X,XXX	0.1%
Milliporesigma Other	~$X,XXX	0.1%
Microvention Other	~$X,XXX	0.1%
Organovo, Inc. Other	~$X,XXX	0.1%
Antheia, Inc. Other	~$X,XXX	0.1%
Polynovo North America Llc Other	~$X,XXX	0.1%
Shire Regenerative Medicine, Inc. Other	~$X,XXX	0.1%
Exelixis Other	~$X,XXX	0.1%
Cv Therapeutics Other	~$X,XXX	0.1%
Herrera & Company Other	~$X,XXX	0.1%
Xoma Other	~$X,XXX	0.1%
Affymax, Inc. Other	~$X,XXX	0.1%
4D Molecular Therapeutics, Inc. Other	~$X,XXX	0.1%
Bridgebio Pharma, Inc. Other	~$X,XXX	0.1%
Pendulum Therapeutics Other	~$X,XXX	0.1%
Versant Ventures Other	~$X,XXX	0.1%
Buck Institute for Research on Aging Other	~$X,XXX	0.1%
Jamey Miller Senior Vice President, Managed Markets & Govt Affairs Us at Glaxo Smith Kline	~$X,XXX	0.1%
Adp, Inc. Other	~$X,XXX	0.1%
Google Healthcare & Life Sciences Other	~$X,XXX	0.1%

Page 8 of 36